{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Continues Crack Down on DTC Advertising: Untitled Letter Highlights Pitfalls in Schizophrenia Drug Promotion",
"url": "https://www.lexblog.com/2026/01/07/fda-continues-crack-down-on-dtc-advertising-untitled-letter-highlights-pitfalls-in-schizophrenia-drug-promotion/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-YAVFCQRD",
"url": "https://www.lexblog.com/lib/YAVFCQRD/"
},
"datePublished": "2026-01-07T19:09:03-05:00",
"dateModified": "2026-01-07T16:09:36-05:00",
"author": {
"@type": "Person",
"name": "Dominick DiSabatino, Julian Klein"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Sheppard, Mullin, Richter & Hampton LLP"
},
"organizationScope": "at-publication",
"about": "Food, Drug & Agriculture",
"sourceUrl": "https://www.fdalawblog.com/?p=2341",
"sourceStability": "may-move"
}